Results for the PIPER Phase 4 study of psoralen-UVA pathogen reduced platelets (PRPC) (Cerus Corporation) following transfusion were recently presented…
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Privacy Policy
